These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

255 related articles for article (PubMed ID: 29271990)

  • 1. MiR-638 inhibits cervical cancer metastasis through Wnt/β-catenin signaling pathway and correlates with prognosis of cervical cancer patients.
    Wei H; Zhang JJ; Tang QL
    Eur Rev Med Pharmacol Sci; 2017 Dec; 21(24):5587-5593. PubMed ID: 29271990
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Long non-coding RNA BLACAT1 promotes cell proliferation, migration and invasion in cervical cancer through activation of Wnt/β-catenin signaling pathway.
    Wang CH; Li YH; Tian HL; Bao XX; Wang ZM
    Eur Rev Med Pharmacol Sci; 2018 May; 22(10):3002-3009. PubMed ID: 29863244
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Upregulation of lncRNA CALML3-AS1 promotes cell proliferation and metastasis in cervical cancer via activation of the Wnt/β-catenin pathway.
    Liu CN; Zhang HY; Liu CL; Wang CC
    Eur Rev Med Pharmacol Sci; 2019 Jul; 23(13):5611-5620. PubMed ID: 31298313
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Long noncoding RNA PCAT6 regulates cell growth and metastasis via Wnt/β-catenin pathway and is a prognosis marker in cervical cancer.
    Lv XJ; Tang Q; Tu YQ; Yan DD; Wei QC
    Eur Rev Med Pharmacol Sci; 2019 Mar; 23(5):1947-1956. PubMed ID: 30915737
    [TBL] [Abstract][Full Text] [Related]  

  • 5. TRIM29 overexpression is associated with poor prognosis and promotes tumor progression by activating Wnt/β-catenin pathway in cervical cancer.
    Xu R; Hu J; Zhang T; Jiang C; Wang HY
    Oncotarget; 2016 May; 7(19):28579-91. PubMed ID: 27081037
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Down-regulation of miR-329-3p is associated with worse prognosis in patients with cervical cancer.
    Chang YH; Yin F; Fan GF; Zhao M
    Eur Rev Med Pharmacol Sci; 2017 Sep; 21(18):4045-4049. PubMed ID: 29028098
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Downregulation of microRNA-145 is associated with aggressive progression and poor prognosis in human cervical cancer.
    Wang Q; Qin J; Chen A; Zhou J; Liu J; Cheng J; Qiu J; Zhang J
    Tumour Biol; 2015 May; 36(5):3703-8. PubMed ID: 25560490
    [TBL] [Abstract][Full Text] [Related]  

  • 8. LncRNA CASC11 promotes the cervical cancer progression by activating Wnt/beta-catenin signaling pathway.
    Hsu W; Liu L; Chen X; Zhang Y; Zhu W
    Biol Res; 2019 Jun; 52(1):33. PubMed ID: 31255182
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Aberrant expression of microRNA-26b and its prognostic potential in human cervical cancer.
    Luo M; Shen D; Wang W; Xian J
    Int J Clin Exp Pathol; 2015; 8(5):5542-8. PubMed ID: 26191262
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Expression of microRNA-142-3p in cervical cancer and its correlation with prognosis.
    Li M; Li BY; Xia H; Jiang LL
    Eur Rev Med Pharmacol Sci; 2017 May; 21(10):2346-2350. PubMed ID: 28617557
    [TBL] [Abstract][Full Text] [Related]  

  • 11. UPK1B promotes the invasion and metastasis of bladder cancer via regulating the Wnt/β-catenin pathway.
    Wang FH; Ma XJ; Xu D; Luo J
    Eur Rev Med Pharmacol Sci; 2018 Sep; 22(17):5471-5480. PubMed ID: 30229818
    [TBL] [Abstract][Full Text] [Related]  

  • 12. miR-378 functions as an onco-miRNA by targeting the ST7L/Wnt/β-catenin pathway in cervical cancer.
    Li S; Yang F; Wang M; Cao W; Yang Z
    Int J Mol Med; 2017 Oct; 40(4):1047-1056. PubMed ID: 28902356
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Long noncoding RNA ROR1‑AS1 overexpression predicts poor prognosis and promotes metastasis by activating Wnt/β-catenin/EMT signaling cascade in cervical cancer.
    Zhang L; Yao HR; Liu SK; Song LL
    Eur Rev Med Pharmacol Sci; 2020 Mar; 24(6):2928-2937. PubMed ID: 32271410
    [TBL] [Abstract][Full Text] [Related]  

  • 14. MiR-27a regulates Wnt/beta-catenin signaling through targeting SFRP1 in glioma.
    Wang K; Xie D; Xie J; Wan Y; Ma L; Qi X; Yang S
    Neuroreport; 2015 Aug; 26(12):695-702. PubMed ID: 26164457
    [TBL] [Abstract][Full Text] [Related]  

  • 15. MiR-122 inhibits epithelial-mesenchymal transition in hepatocellular carcinoma by targeting Snail1 and Snail2 and suppressing WNT/β-cadherin signaling pathway.
    Jin Y; Wang J; Han J; Luo D; Sun Z
    Exp Cell Res; 2017 Nov; 360(2):210-217. PubMed ID: 28890291
    [TBL] [Abstract][Full Text] [Related]  

  • 16. CRIP1 promotes cell migration, invasion and epithelial-mesenchymal transition of cervical cancer by activating the Wnt/β‑catenin signaling pathway.
    Zhang LZ; Huang LY; Huang AL; Liu JX; Yang F
    Life Sci; 2018 Aug; 207():420-427. PubMed ID: 29959029
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Decreased microRNA-206 and its function in cervical cancer.
    Ling S; Ruiqin M; Guohong Z; Bing S; Yanshan C
    Eur J Gynaecol Oncol; 2015; 36(6):716-21. PubMed ID: 26775359
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Upregulated miR-155 in papillary thyroid carcinoma promotes tumor growth by targeting APC and activating Wnt/β-catenin signaling.
    Zhang X; Li M; Zuo K; Li D; Ye M; Ding L; Cai H; Fu D; Fan Y; Lv Z
    J Clin Endocrinol Metab; 2013 Aug; 98(8):E1305-13. PubMed ID: 23796566
    [TBL] [Abstract][Full Text] [Related]  

  • 19. MiR-34a Inhibits Breast Cancer Proliferation and Progression by Targeting Wnt1 in Wnt/β-Catenin Signaling Pathway.
    Si W; Li Y; Shao H; Hu R; Wang W; Zhang K; Yang Q
    Am J Med Sci; 2016 Aug; 352(2):191-9. PubMed ID: 27524218
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Highly expressed long non-coding RNA NNT-AS1 promotes cell proliferation and invasion through Wnt/β-catenin signaling pathway in cervical cancer.
    Hua F; Liu S; Zhu L; Ma N; Jiang S; Yang J
    Biomed Pharmacother; 2017 Aug; 92():1128-1134. PubMed ID: 28628975
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.